Nuvectis Pharma Inc. (NVCT)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
5.46
-0.18 (-3.19%)
At close: Jan 15, 2025, 3:59 PM
5.37
-1.65%
After-hours Jan 15, 2025, 04:00 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 |
PE Ratio | -5.83 | -5.05 | -3.21 | -4.13K |
PS Ratio | n/a | 637.13 | n/a | n/a |
PB Ratio | 10.63 | 6.68 | -3.75 | -4.13K |
P/FCF Ratio | -8.13 | -7 | -4.35 | 1.72K |
P/OCF Ratio | -8.13 | -7 | -4.35 | 1.72K |
OCF/S Ratio | n/a | -91 | n/a | n/a |
Debt / Equity Ratio | n/a | n/a | n/a | n/a |
Quick Ratio | 2.75 | 3.30 | 2.41 | n/a |
Current Ratio | 2.75 | 3.30 | 2.41 | n/a |
Asset Turnover | n/a | 0.01 | n/a | n/a |
Interest Coverage | n/a | -129.09 | n/a | n/a |
Return on Equity (ROE) | -1.82 | -1.32 | 1.17 | 1.00 |
Return on Assets (ROA) | -1.16 | -0.92 | -1.94 | n/a |
Return on Capital (ROIC) | -1.88 | -1.35 | -3.04 | 1.00 |
Dividend Yield | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | -12.81K% | n/a | n/a |
Net Profit Margin | n/a | -12.61K% | n/a | n/a |
Pretax Profit Margin | n/a | -12.81K% | n/a | n/a |
Operating Profit Margin | n/a | -12.91K% | n/a | n/a |
FCF Margin | n/a | -9.10K% | n/a | n/a |
EBITDA Margin | n/a | -12.91K% | n/a | n/a |